Psychosis - Articles - Page 2 | CARLAT PUBLISHING

Research Update

Are Higher-Potency Cannabis Products Riskier for Mental Illness?

April 1, 2023

John Wang, MD, and Deepti Anbarasan, MD. Dr. Wang and Dr. Anbarasan have no financial relationships with companies related to this material.

In recent years, cannabis with widely varying THC concentrations has become available. But is there a link between how much THC a cannabis product contains and its risk of adverse effects. Researchers here add to the mounting evidence that the answer is likely yes.

Expert Q&A

Recognizing and Treating Substance-Induced Psychosis

April 1, 2023

David Beckmann, MD, MPH

David Beckmann, MD, MPH.

Assistant professor of psychiatry and human behavior, Sidney Kimmel Medical College, Thomas Jefferson University. Philadelphia, PA.

Dr. Beckmann has no financial relationships with companies related to this material.

Clinical pearls on how to assess and treat substance-induced psychosis when you come across them in your clinic.

BOOK REVIEWS FOR PSYCHIATRISTS

Using Stories to Color the Stark Lines of Evidence-Based Medicine: Elyn R. Saks

February 9, 2023

Emily E. Whisler, DO and Edmund S. Higgins, MD.

The first in a series of interesting reading for psychiatrists

RESEARCH UPDATE

Aripiprazole-Related Psychotic Exacerbations

January 1, 2023

Brian Miller, MD, PhD, MPH.

Brian Miller, MD, PhD, MPH. Dr. Miller, author of this educational activity, receives research support from Augusta University, the National Institute of Mental Health, the Brain and Behavior Research Foundation, and the Stanley Medical Research Institute. Relevant financial relationships listed for the author have been mitigated.

This study identifies a common clinical scenario where aripiprazole may trigger psychotic symptoms.

CLINICAL UPDATE

Who's Who? A Review of Delusional Misidentification Syndromes

October 1, 2022

Adrienne Grzenda, MD, PhD.

Adrienne Grzenda, MD. Clinical Assistant Professor of Psychiatry & Biobehavioral Sciences, UCLA David Geffen School of Medicine and Olive View UCLA Medical Center, Los Angeles, CA. Dr. Grzenda, author for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

You have probably encountered patients who adamantly insist a loved one has been replaced by an impostor. Here are tips for how to treat them.

RESEARCH UPDATE

Can Pimavanserin Treat Psychosis in Patients With Dementia?

October 1, 2022

James Black, MD

James Black, MD. Dr. Black, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

This study suggests that patients started on pimavanserin for dementia and psychosis should probably continue it to prevent relapse, but we will need more data for clarity given flaws in the study design.

10 Psychopharm Commandments #1

September 5, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Antidepressants in mania and stimulants in psychotic disorders get called out in our first psychopharm commandment.

Psychosis During Depression

August 23, 2022

Conrad M. Swartz, MD, PhD

Conrad M. Swartz, MD, PhD. Professor Emeritus, Southern Illinois University, Springfield, IL. Dr. Swartz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psychotic depression is difficult to detect, and antipsychotics are not as effective in this condition as we’d like to think. Conrad Swartz explains why 1 in 3 cases of psychotic depression are missed, its complex relationship to trauma, and how to treat it.

EXPERT Q&A

Raising the Bar in Schizophrenia Treatment

January 31, 2022

Brian Miller, MD, PhD, MPH

Brian Miller, MD, PhD, MPH Professor of Psychiatry at the Medical College of Georgia, Augusta, and President of the Georgia Psychiatric Physicians Association. Dr. Miller receives research support from Augusta University, the National Institute of Mental Health, the Brain and Behavior Research Foundation, and the Stanley Medical Research Institute.

Dr. Miller discusses new options for negative symptoms, how to improve the therapeutic alliance, and what to do when clozapine doesn’t work in schizophrenia.

RESEARCH UPDATE

Antipsychotics for Methamphetamine Psychosis

January 18, 2022

Sanya Virani, MD.

Sanya Virani, MD. Dr. Virani has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this network meta-analysis, researchers compared different antipsychotics head-to-head for the treatment of methamphetamine psychosis and found some clear winners are losers.